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ABSTRACT
With a longitudinal (2020–2021) completion, a set of 300 urine samples of individuals
suspected of UTI was characterized based on the biochemical analysis and Kirby Bauer's disc
diffusion method. Throughout, a total of 167 samples revealed UTI positivity by obtaining
bacterial growth. Reporting that E. coli (69.4 %) was the most dominant when compared with
Klebsiella (14.3 %), Proteus (5.9 %), S. aureus (4.7 %), P. aeruginosa (3.5 %), and
Enterobacter (1.7 %), respectively. Gender-wise discrimination showed that E. coli was
highly distributed among female (50.2 %) patients. A prominent percentage of E. coli (41.9
%) was found in the age group between 21-40 years. Isolates of E. coli represented the
highest degree of resistance to Amoxicillin and Ceftriaxone (85.3 %), while highly sensitive
to Amikacin, and Tazobactam (94.8 %). S. aureus was found highly resistant to Amoxicillin,
Levofloxacin, Sulbactam, and Doxycycline (75 %), while highly sensitive to Meropenem,
and Cefotaxime (100 %). Proteus spp. was found highly resistant to Sulbactam, and
Cefotaxime (100 %), while highly sensitive to Tazobactam (100 %). Enterobacter was found
highly resistant to Gentamicin (100 %), while highly sensitive to Aztreonam (100 %).
Klebsiella was found highly resistant to Levofloxacin, and Doxycycline (91.6 %), while
highly sensitive to Amikacin, Tazobactam, Gentamicin, and Cefoxitin (75 %). P. aeruginosa
was found highly resistant to Nalidixic acid (100 %), while highly sensitive to Meropenem,
Ceftriaxone, Gentamicin, and Cefotaxime. In conclusion, the Amikacin and Tazobactam were
seen to be effective for empirical therapy of UTI.
Keywords: Epidemiology, antibiotic sensitivity pattern, uropathogens, Peshawar.
found in outpatients, and could also be
INTRODUCTION
caused by certain fungi and viruses as well
as
bacteria
(Flores-Mireles
et
Urinary tract infection (UTI) is one
al., 2015). According to the authors, more
of the most significant bacterial infections
than 80 % of UTI is caused by Gramin the 21st century causing various types
negative bacteria and other due to Gramof health concerns in both males and
positive bacteria. Many factors are
females. Although both genders are
associated with the prevalence of UTI
exposed to the infection, women are more
particularly the presence of more than 105
susceptible due to their reproductive
CFU/ml bacteria in the urine. Escherichia
physiology and morphology as compared
coli is the most prevalent uropathogen (60to males (Vasudevan, 2015). UTI is one of
90 %), followed by Staphylococcus
the most widespread infectious diseases
species accounts for 10-15 % UTIs.
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In addition, other bacterial species
such as Streptococcus, Proteus, Klebsiella,
Neisseria,
Corynebacterium,
and
Pseudomonas are also isolated from
patients with UTI also reported (Ashur et
al., 2021; Seifu and Gebissa, 2018). UTI is
symptomatic sometimes but typically the
clinical symptoms of UTI include urgency,
painful urination, feelings of urination
after urination, dysuria, pyuria, pain in the
back, and abdominal pain. Other hostrelated factors increase the rate of urinary
tract infection, including; urine factors,
sexual factors, osmolality, vaginal pH, and
secretory condition (Nigussie and Amsalu,
2017).
The treatment of UTI is a big
hurdle for physicians. The emergence of
antibiotic resistance among uropathogens
has increased globally and become a
serious public health issue especially in
low-income countries (Ejerssa et al.,
2021). According to a recent study in
Europe, UTI treatment accounts for 9 % of
all antibiotic prescriptions, and patients
with UTIs showed resistance to antibiotics
in a high ratio. Drug-resistant bacterial
strains, as well as the high prevalence of
UTI, underline the need for a better
understanding of the microorganisms that
cause UTI and their pattern of antibiotic
resistance (Folliero et al., 2020). The
severity of a UTI is dictated by the
virulence of the bacteria as well as the
host's susceptibility (Hannan et al., 2012).
Because of antibiotic overuse, uropathogen
isolates now have an unacceptably high
proportion of resistance to practically all
antibiotics across the world (Khan et al.,
2021; Gebremariam et al., 2019).
In context to an abovementioned
health issue, the current study was
designed
to
investigate
the
epidemiological status of uropathogens, as
well as their pattern of resistance to
commonly used antibiotics, in physicianreferred UTI patients in Peshawar,
Pakistan.

MATERIALS AND METHODS
Study Design
A cross-sectional study was
conducted from February 2020 to January
2021 at Complex medical laboratory and
Diagnostic Center, Peshawar, Pakistan.
Samples Collection and Handling
Total 300 urine samples from UTI
suspect patients referred by physicians
were undertaken at the Complex medical
laboratory and Diagnostic Center in
Peshawar, Pakistan. Clean capture midstream urine samples were obtained and
labeled from all UTI suspicion patients.
The patients' names, ages, genders, clinical
histories, and treatment histories were
recorded. The following four age groups
were included in this study ≤20, 21-40, 4160, and ≥61 years.
Initial Examination of Urine samples
Initially, urine samples were
screened for nitrite, protein, glucose,
ketone bodies, bilirubin, bile pigments, red
blood cells, and pus cells by visual,
dipstick, and microscopic examination.
Urine culture samples had more than four
leukocytes per field, more than two red
blood cells per field, numerous epithelial
cells, and crystals (Cristina et al., 2009).
Isolation of Bacteria
Urine samples were streaked on
Blood agar medium and MacConkey Agar
media with a 0.01 mL calibrated wire loop.
For 24 hours, at 37oC aerobically, all
plates were incubated. Positive samples
showed growth, and isolated colonies were
Gram stained. The pure isolated colony
culture was then processed for biochemical
examination to identify pathogens. To
identify uropathogens, the following tests
were performed: Oxidase test, Catalase
test, Indole test Urease test, Citrate,
Utilization test, Methyl red test, H2S,
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Voges Proskauer test, Gas output test, and
Motility test (Khan et al., 2021).
Antibiotic Susceptibility Testing
The concentration of antibiotics
discs (Oxoid, Ltd, England) used in the
Kirby Bauer's disc diffusion test and
Clinical and Laboratory Standards Institute
(CLSI), 2019 standards was Amoxicillin
(AMC) 30 µg, Amikacin (AK) 30 µg,
Levofloxacin (LEV) 5 µg, Tazobactam
(TZP) 110 µg, Meropenem (MEM) 10 µg,
Sulbactam (SAM) 20 µg, Ceftriaxone
(CRO) 30 µg, Ciprofloxacin (CIP) 5 µg,
Cefotaxime (CTX) 30 µg, Doxycycline
(DXT) 30 µg, Aztreonam (ATM) 30 µg,
Nalidixic acid (NA) 30 µg, Gentamicin
(CN) 10 µg, and Cefoxitin (FOX) 30 µg.
The inoculum was prepared for 2 mL of
Muller Hinton broth and cultured for 4
hours at 37oC to generate fresh culture and
then applied to the McFarland 0.5
standard. The Muller Hinton agar plate
surface was stripped with a sterile cotton
swab that had been submerged in the
solution. Aseptically, antibiotic discs were
placed with sterile forceps on the agar
surface and for 24 hours the plates were
incubated at 37oC. After incubation,
millimeter calipers were used to measure
the widths of the zones of complete
inhibition (Khan et al., 2021).
Quality Control
Reference strain stranded for
quality control for culture and sensitivity
checking, E. coli (ATCC 25922) was used.
The zone of isolate inhibition was graded
as susceptible and resistant according to
CLSI criteria (29th Edition CLSI, 2019).
ETHICAL STATEMENT
The Complex Medical Laboratory
and Diagnostic Center in Peshawar and
Abasyn University in Peshawar, Pakistan,
ethical committees approved the study.

RESULTS
A total of 300 urine samples were
investigated for UTI. Among these, 167
(55.6 %) were positive for bacterial growth
in both genders (20-61 years age). The
most frequent bacterial isolates were E.
coli n=116 (69.4 %), followed by
Klebsiella spp. n=24 (14.3 %), Proteus
spp. n=10 (5.9 %), S. aureus n=8 (4.7 %),
P. aeruginosa, n=6 (3.5 %) and
Enterobacter n=3 (1.7 %) respectively
(Fig. 1). The current study reported high
frequency of E. coli in female(s) n=84
(50.2 %) as compared with n=32 (19.1 %).
The highest frequency of Gram-negative
isolates E. coli n=70 (41.9 %) age group
range from 21-40 years, followed by
vulnerable 41-60 years with n=20 (11.9
%), n=14 (8.3 %) ≥61 years, n=12 (7.1 %)
(Table 1).
It was observed that E. coli strains
displayed relatively highest degree of
resistance to Amoxicillin and Ceftriaxone
(85.3 %), while highly sensitive to
Amikacin, and Tazobactam (94.8 %). S.
aureus was found highly resistant to
Amoxicillin, Levofloxacin, Sulbactam,
and Doxycycline (75 %), while highly
sensitive to Meropenem, and Cefotaxime
(100 %). Proteus spp. was found highly
resistant to Sulbactam, and Cefotaxime
(100 %), while highly sensitive to
Tazobactam (100 %). Enterobacter was
found highly resistant to Gentamicin (100
%), while highly sensitive to Aztreonam
(100 %). Klebsiella spp. was found highly
resistant to Levofloxacin, and Doxycycline
(91.6 %), while highly sensitive to
Amikacin, Tazobactam, Gentamicin, and
Cefoxitin (75 %). P. aeruginosa was found
highly resistant to Nalidixic acid (100 %),
while highly sensitive to Meropenem,
Ceftriaxone, Gentamicin, and Cefotaxime
(100 %) (Table 2).
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Figure 1: Overall distribution of Uropathogens.
Table 1: Overall, gender wise and age wise distribution of Uropathogens.
Overall Etiology of Uropathogens

Total =
167

E. coli
n ( %)

S. aureus
n ( %)

Proteus spp.
n ( %)

Enterobacter
n ( %)

Klebsiella spp.
n ( %)

P. aeruginosa
n ( %)

116 (69.4 %)

8 (4.7 %)

10 (5.9 %)

3 (1.7 %)

24 (14.3 %)

6 (3.5 %)

Gender Wise Etiology of Uropathogens
Male

32 (19.1 %)

6 (3.5 %)

8 (4.7 %)

1 (0.5 %)

10 (5.9 %)

5 (2.9 %)

Female

84 (50.2 %)

2 (1.1 %)

2 (1.1 %)

2 (1.1 %)

14 (8.3 %)

1 (0.5 %)

Age Wise Etiology of Uropathogens
≤20

12 (7.1 %)

1 (0.5 %)

1 (0.5 %)

0 (0 %)

4 (2.3 %)

1 (0.5 %)

21-40

70 (41.9 %)

3 (1.7 %)

5 (2.9 %)

2 (1.1 %)

11 (6.5 %)

3 (1.7 %)

41-60

20 (11.9 %)

3 (1.7 %)

3 (1.7 %)

1 (0.5 %)

6 (3.5 %)

2 (1.1 %)

≥61

14 (8.3 %)

1 (0.5 %)

1 (0.5 %)

0 (0 %)

3 (1.7 %)

0 (0 %)
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Table 2: Antibiotics sensitivity and resistance pattern of Uropathogens.
E. coli
(n=116)

S. aureus
(n=08)

Proteus spp.
(n=10)

Enterobacter
(n=03)

Klebsiella spp.
(n=24)

P. aeruginosa
(n=06)

Antibiotics Disc
S
(%)
Amikacin (AK)
30µg
Amoxicillin
(AMC) 30µg
Levofloxacin
(LEV) 5µg
Ciprofloxacin
(CIP) 5µg
Tazobactam
(TZP) 110µg

110
(94.8
%)
17
(14.6
%)
57
(49.1
%)
40
(34.4
%)
110
(94.8
%)

Meropenem
(MEM) 10µg

87 (75
%)

Sulbactam
(SAM) 20µg

29 (25
%)

Ceftriaxone
(CRO) 30µg

17
(14.6
%)

Gentamicin
(CN) 10µg

58 (50
%)

Cefotaxime
(CTX) 30µg

29 (25
%)

Doxycycline
(DXT) 30µg
Aztreonam
(ATM) 30µg
Nalidixic acid
(NA) 30µg
Cefoxitin (FOX)
30µg

45
(38.7
%)
23
(19.8
%)
23
(19.8
%)
87 (75
%)

R
(%)

S
(%)

R
(%)

S
(%)

R
(%)

S
(%)

R
(%)

S
(%)

R
(%)

S
(%)

R
(%)

6 (5.1
%)

4 (50
%)

4(50 %)

8 (80
%)

2 (20
%)

3 (100
%)

0 (0 %)

18 (75
%)

6 (25
%)

5(83.3
%)

1(16.6
%)

2 (25
%)

6 (75
%)

9 (90
%)

1 (10
%)

2 (66.6
%)

1 (33.3
%)

6 (25
%)

18 (75
%)

3(50 %)

3(50
%)

2 (25
%)

6 (75
%)

2 (20
%)

8 (80
%)

3 (100
%)

0 (0 %)

2 (8.3
%)

22 (91.6
%)

4(66.6
%)

2(33.3
%)

5 (62.5
%)

5 (50
%)

5 (50
%)

3 (100
%)

0 (0 %)

10
(41.6
%)

14 (58.3
%)

4(66.6
%)

2(33.3
%)

1 (12.5
%)

10
(100
%)

0 (0 %)

1 (33.3
%)

2 (66.6
%)

18 (75
%)

6 (25
%)

3(50 %)

3(50
%)

8 (100
%)

0 (0 %)

9 (90
%)

1 (10
%)

3 (100
%)

0 (0 %)

12 (50
%)

12 (50
%)

6(100
%)

0(0 %)

2 (25
%)

6 (75
%)

0 (0
%)

10 (100
%)

3 (100
%)

0 (0 %)

4 (16.6
%)

20 (83.3
%)

4(66.6
%)

2(33.3
%)

1 (12.5
%)

2 (20
%)

8 (80
%)

1 (33.3
%)

2 (66.6
%)

10
(41.6
%)

14 (58.3
%)

6(100
%)

0(0 %)

1 (12.5
%)

8 (80
%)

2 (20
%)

0 (0
%)

3 (100
%)

18 (75
%)

6 (25
%)

6(100
%)

0(0 %)

8 (100
%)

0 (0 %)

0 (0
%)

10 (100
%)

3 (100
%)

0 (0 %)

6 (25
%)

18 (75
%)

6(100
%)

0(0 %)

2 (25
%)

6 (75
%)

9 (90
%)

1 (10
%)

2 (66.6
%)

1 (33.3
%)

2 (8.3
%)

22 (91.6
%)

1(16.6
%)

5(83.3
%)

4 (50
%)

4(50 %)

2 (20
%)

8 (80
%)

0 (0
%)

3 (100
%)

12 (50
%)

12 (50
%)

1(16.6
%)

5(83.3
%)

5 (62.5
%)

9 (90
%)

1 (10
%)

2 (66.6
%)

1 (33.3
%)

12 (50
%)

12 (50
%)

0(0 %)

6(100
%)

1 (12.5
%)

8 (80
%)

2 (20
%)

1 (33.3
%)

2 (66.6
%)

18 (75
%)

6 (25
%)

1(16.6
%)

5(83.3
%)

99
(85.3
%)
59
(50.8
%)
76
(65.5
%)
6 (5.1
%)
29
(25
%)
87
(75
%)
99
(85.3
%)
58
(50
%)
87
(75
%)
71
(61.2
%)
93
(80.1
%)
93
(80.1
%)
29
(25
%)

3
(37.5
%)
7
(87.5
%)

7
(87.5
%)
7
(87.5
%)

3
(37.5
%)
7
(87.5
%)

DISCUSSION
The over or misuse of antibiotics to
treat
infections
has
deleterious
consequences on public health as well as
socio-economic impact and that increase
resistance among causative agents such as
bacteria. In context to this, it is critical to

assess the status of antimicrobial resistance
in the community. The main objective of
this study is to achieve this goal in UTI
patients. In this study prevalence of UTI in
referred outpatients was 55.6 %, the study
has
similar
findings
(80
%)
with Sangsuwan et al., (2021) study
conducted in Thailand (Sangsuwan et al.,
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2021). The current study investigated 300
urine samples 167 study samples E.
coli were found in (69.4 %) patients, E.
coli were high in female (50.2 %) patients,
while in males were (19.1 %). In different
studies conducted, similarly elevated
prevalence rates of UTI incidence in
women were identified include Turkey
(82.30 %), Iran (86.24 %), Saudi Arab
(60.35 %), Pakistan (69.80 %), and Italy
(60 %) (Sabir et al., 2014; Khan et al.,
2014; Al-Mijalli et al., 2017; Farajnia,
2009; Folliero et al., 2020). The present
study also revealed the age group 21-40
years as the most susceptible group to E.
coli (69.4 %) among the uropathogens.
Our findings based on age group are
similar to the study conducted by Shabir et
al. 2017 in Peshawar, Pakistan. The
authors revealed patients with age group
susceptibility to E. coli that can be ordered
from 41 to 60 years of age (11.9 %), from
≥60 years of age (8.3 %), and from ≤20
years of age (7.1 %). The current study is
inconsistent with a previously conducted
study where 65 % of patients with age >60
years
were
more
exposed
to
infection (Sangsuwan et al., 2021). The
aforementioned variation in incidence
could be explained by geography
differences, and other associated factors
such as social habits, personal hygiene,
and health education awareness and
practices. Inlined with higher maximum
UTI cases in women certain factors may
be associated including the small urethra,
deficiency of germicidal substances in
prostatic fluid, hormonal imbalance (Akter
et al., 2016). The current study observed E.
coli as the most frequent uropathogen (69
%) in UTI. Our findings in this context are
in accordance with previously conducted
studies in Pakistan and also other parts of
the
world
(Seifu
and
Gebissa,
2018; Folliero et al., 2020; Qazi &
Ainuddin, 2021; Shabir et al., 2017). The
current study also observed that E. coli is
sensitive to Amikacin, and Tazobactam
(94.8 %). This study is consistent with
previous studies where the sensitivity rate

to Amikacin was (92.5 %) and to
Tazobactam was (96.2 %) (Ho et al.,
2019; Sangsuwan et al., 2021; Shabir et
al., 2017; Hussain et al., 2021).
In addition, high levels of
resistance were noted to Ceftriaxone and
Amoxicillin were (85.3 %); Aztreonam
and Nalidixic Acid were (80.1 %). This
finding of high Ceftriaxone resistance
correlates with the previous study
conducted by Shabir et al., 2017 in
Peshawar, Pakistan, where the resistance
rate to Ceftriaxone was (78.0 %).
Increasing resistance (over 60 %) of the
UTI strain to Nalidixic Acid was also seen
in a study in Pakistan (Liaqat et al., 2014).
Similar studies in Iraq, on the other hand,
found a lower resistance rate (25.9 %) of
the E. coli strain to Nalidixic Acid
(Aaboda and Notazy, 2018). Resistance to
Nalidixic Acid is suspected to have arisen
because of the overabundant use of firstgeneration quinolone Nalidixic Acid for
the treatment of UTI (Akter et al., 2016;
Johnson et al., 2003).
CONCLUSION
The present study concluded that
E. coli is the most prevalent uropathogens
followed by Klebsiella spp., Proteus spp.,
S. aureus, P. aeruginosa, and Enterobacter
in the study area. The highest percentage
uropathogens were found in females and
21-40 age groups. Amikacin and
Tazobactam were found effective for
empirical therapy of UTI from the
antimicrobial susceptibility profile. It is
also recommended that doctors examine
the Antibiotic resistance to a patient's
prescription UTI pathogen. Usage of
antibiotics to combat infections and their
resistance is important to track and
regulate. Future studies are suggested for
the detection of other UTI isolates and the
use of all antibiotics in assessing elaborate
susceptibility trends.
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